19 June 2013 19:45


News
Twitter RSS Newsletter Send to a friend
0

BMJ Informatica launches Prescribing+

17 July 2012  

BMJ Informatica has launched a software tool to help GPs and commissioners improve the safety and quality of their prescribing.

Prescribing+ has been developed by BMJ Informatica in conjunction with Eclipse Solutions.

It provides clinicians with immediate support when initiating acute and repeat prescriptions by suggesting safe, appropriateand cost efficient alternative medications. 

It includes links to the British National Forumulary and the Medicines and Healthcare products Regulatory Agency.

A BMJ statement says Prescribing+ has been designed so that it doesn’t interrupt or delay the prescribingprocess during patient consultations.

“GPs can be confident that decisionsare based on the latest data about the effectiveness and pricing of anymedicines and they are alerted immediately to safety recalls,” it says.

Prescribing+ also provides a specialised auditing feature enabling a desktop review with access to the patient record and drug optimisation details.

Middlesbrough GP Dr David Royal said: “The new Prescribing+ software enables GPs to retain control of their prescribing, whilst facilitating the implementation of locally agreed policies and guidance."

 


Related Articles:

News: Torbay CCG buys Contract+ for practices | 23 February 2012
1 News: BMJ Group releases apps for docs | 17 June 2011
News: Informatica updates QoF software | 13 April 2011
News: BMJ Group buys GP software company | 5 January 2011
Last updated: 16 July 2012 15:50

© 2012 EHealth Media.


Please wait... loading

 
Add a comment

Register: To add a comment you must be registered.

Register

 

Login:

Email address:


Forgot your email address?contact


 
Password:


Forgot your password?prompt

 

Remember me

Login



EHealth Media Limited
EHealth Insider is managed and maintained by EHealth Media © 2013
Registered Office: 11 Campana Road, London SW6 4AS
Registered No. 4214439 | Vat No. 774 4008 29
About us | Advertise | Terms and conditions | Privacy policy | Cookie policy | Contact us